Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures.

dc.contributor.authorGuañabens Gay, Núria
dc.contributor.authorPeris Bernal, Pilar
dc.contributor.authorBlasco, Jordi
dc.contributor.authorMonegal Brancós, Ana
dc.contributor.authorFlorez, Helena
dc.contributor.authorCarrasco Jordan, Josep Lluís
dc.date.accessioned2025-03-27T09:29:45Z
dc.date.available2025-03-27T09:29:45Z
dc.date.issued2023-11-30
dc.date.updated2025-03-27T09:29:45Z
dc.description.abstractSummary: The evolution of pain and quality of life after a symptomatic vertebral fracture difers according to patient gender, with a worse evolution in women independently of the treatment received. Purpose In a previous randomized clinical study comparing the efect of vertebroplasty (VP) vs. conservative therapy (CT) on pain evolution and quality of life (QoL) of patients with symptomatic vertebral fractures (VF), we observed the development of chronic back pain in 23% of subjects, independently of the therapy received. This study analyses the efect of gender on the evolution of pain and QoL in these subjects. Methods: 118/125 randomized patients (27 males/91 females) with recent symptomatic VFs were evaluated. All received a standardized analgesic and antiosteoporotic format of treatment. Pain and QoL were evaluated by VAS and Qualefo-41, respectively, at baseline, at 2 weeks and 2 and 6 months. We compared pain evolution and QoL after treatment (CT vs. VP) according to gender, and analysed factors including age, time of evolution, treatment received, baseline VAS, previous VFs (total and recent), incidental VFs, lumbar and femoral T-scores, and analgesic and antiosteoporotic treatment. Results: At baseline, there were no diferences in age (males 74.8±11.2 vs. females:73.2±8.7 years), time of evolution, number of VFs (males:3.8±2.4 vs. females: 3.1±2.4), treatment received (VP, males:59%, females:45%), lumbar or femoral T-score, baseline VAS (males:6.8±2.1 vs. females:6.8±2.2) or Qualefo score (males:52.2±24.4 vs. females:59.7±20.6). Pain and QoL evolution difered according to gender, being better in males. These diferences were signifcant after two months independently of the treatment and the development of incidental VF during follow-up. Conclusions: Pain and QoL evolution after a symptomatic VF difers according to gender, with a worse evolution in women independently of the treatment received.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec741347
dc.identifier.issn0937-941X
dc.identifier.urihttps://hdl.handle.net/2445/220056
dc.language.isoeng
dc.publisherSpringer Verlag
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1007/s00198-023-06960-y
dc.relation.ispartofOsteoporosis International, 2023, vol. 35, num.3, p. 515-521
dc.relation.urihttps://doi.org/10.1007/s00198-023-06960-y
dc.rightscc by-nc (c) Guañabens Gay, Núria et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationVèrtebres
dc.subject.classificationGènere
dc.subject.classificationDolor
dc.subject.classificationSexualitat
dc.subject.classificationQualitat de vida
dc.subject.classificationFractures
dc.subject.classificationOsteoporosi
dc.subject.otherVertebrae
dc.subject.otherGender
dc.subject.otherPain
dc.subject.otherSex
dc.subject.otherQuality of life
dc.subject.otherFractures
dc.subject.otherOsteoporosis
dc.titleEffect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fractures.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
838641.pdf
Mida:
567.6 KB
Format:
Adobe Portable Document Format